Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia

Schizophrenia Research

Volumn 130, Issue 1-3, 2011, Pages 266-270

  Rubin, Leah H ^a   Carter, C Sue ^a   Drogos, Lauren ^a   Jamadar, Rhoda ^a   Pournajafi Nazarloo, Hossein ^a   Sweeney, John A ^a   Maki, Pauline M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Emotion perception; Emotion recognition; Menstrual cycle; Oxytocin; Schizophrenia; Social cognition

Indexed keywords

ESTROGEN; OXYTOCIN; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTION; ESTROGEN BLOOD LEVEL; FACIAL EXPRESSION; FEMALE; FOLLICULAR PHASE; HAPPINESS; HUMAN; MALE; MENSTRUAL CYCLE; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SCHIZOPHRENIA; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; EMOTIONS; FEMALE; HORMONES; HUMANS; MALE; MENSTRUAL CYCLE; OXYTOCIN; PERCEPTION; PHOTIC STIMULATION; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79960306770     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.06.002     Document Type: Article

References (23)

1. Champagne F., Diorio J., Sharma S., Meaney M.J. Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc. Natl. Acad. Sci. U.S.A 2001, 98:12736-12741.
2. Derntl B., Kryspin-Exner I., Fernbach E., Moser E., Habel U. Emotion recognition accuracy in healthy young females is associated with cycle phase. Horm. Behav. 2008, 53:90-95.
3. Derntl B., Windischberger C., Robinson S., Lamplmayr E., Kryspin-Exner I., Gur R.C., Moser E., Habel U. Facial emotion recognition and amygdala activation are associated with menstrual cycle phase. Psychoneuroendocrinology 2008, 33:1031-1040.
4. Di Simplicio M., Massey-Chase R., Cowen P., Harmer C. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J. Psychopharmacol. 2009, 23(3):241-248.
5. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
6. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010, 35:83-93.
7. Erwin R.J., Gur R.C., Gur R.E., Skolnick B., Mawhinney-Hee M., Smailis J. Facial emotion discrimination: I. Task construction behavioral findings in normal subjects. Psychiatry Res. 1992, 42:231-240.
8. Feifel D., Macdonald K., Nguyen A., Cobb P., Warlan H., Galangue B., Minassian A., Becker O., Cooper J., Perry W., Lefebvre M., Gonzales J., Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol. Psychiatry 2010, 68(7):678-680.
9. Goldman M.B., Gomes A.M., Carter C.S., Lee R. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology (Berl) 2011, 216(1):101-110.
10. Guapo V.G., Graeff F.G., Zani A.C., Labate C.M., dos Reis R.M., Del-Ben C.M. Effects of sex hormonal levels and phases of the menstrual cycle in the processing of emotional faces. Psychoneuroendocrinology 2009, 34:1087-1094.
11. Kohler C.G., Bilker W., Hagendoorn M., Gur R.E., Gur R.C. Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol. Psychiatry 2000, 48:127-136.
12. Lehman A.F., Kreyenbuhl J., Buchanan R.W., Dickerson F.B., Dixon L.B., Goldberg R., Green-Paden L.D., Tenhula W.N., Boerescu D., Tek C., Sandson N., Steinwachs D.M. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr. Bull. 2004, 30:193-217.
13. Marsh A.A., Yu H.H., Pine D.S., Blair R.J. Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology (Berl) 2010, 209:225-232.
14. McCarthy M.M., McDonald C.H., Brooks P.J., Goldman D. An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol. Behav. 1996, 60:1209-1215.
15. Pearson R., Lewis M.B. Fear recognition across the menstrual cycle. Horm. Behav. 2005, 47:267-271.
16. Rauch A.V., Reker M., Ohrmann P., Pedersen A., Bauer J., Dannlowski U., Harding L., Koelkebeck K., Konrad C., Kugel H., Arolt V., Heindel W., Suslow T. Increased amygdala activation during automatic processing of facial emotion in schizophrenia. Psychiatry Res. 2010, 182:200-206.
17. Razzoli M., Cushing B.S., Carter C.S., Valsecchi P. Hormonal regulation of agonistic and affiliative behavior in female mongolian gerbils (Meriones unguiculatus). Horm. Behav. 2003, 43:549-553.
18. Rubin L.H., Carter C.S., Drogos L., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr. Res. 2010, 124:13-21.
19. Scholten M.R., Aleman A., Montagne B., Kahn R.S. Schizophrenia and processing of facial emotions: sex matters. Schizophr. Res. 2005, 78:61-67.
20. Thayer J.F., Johnsen B.H. Sex differences in judgement of facial affect: a multivariate analysis of recognition errors. Scand. J. Psychol. 2000, 41:243-246.
21. Williams L.M., Mathersul D., Palmer D.M., Gur R.C., Gur R.E., Gordon E. Explicit identification and implicit recognition of facial emotions: I. Age effects in males and females across 10 decades. J. Clin. Exp. Neuropsychol. 2009, 31:257-277.
22. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64:663-667.
23. Ziv I., Leiser D., Levine J. Social cognition in schizophrenia: cognitive and affective factors. Cogn. Neuropsychiatry 2011, 16:71-91.